Ale's World of Stocks 对 $FRNM 的判断变化

Ale's World of Stocks 自 2026-11-15 起在 1 个视频里谈过 $FRNM。

2026-11-15
《Google is Betting $1.2B on These 5 Crashing Stocks 🚨》
AI 摘要 · 对说话者而言,FRNM 属于中性、暂不买入的标的。其结肠癌血液检测已获 FDA 批准,肺癌检测获得突破性认定,并已有推广合作伙伴;但高销售增长并未减少亏损,亏损持平或恶化;美国结肠检测销售掌握在同时拥有竞争性检测的合作伙伴手中,这一利益冲突需持续关注,且行业进入门槛较低。他看好其长期潜力,但将 FRNM 排在略低于一家更高增长同行的位置(尽管 FRNM 最低买入价更高,若在两者中投入 1,000 美元,他会选择该同行),且不会很快买入,需要数年业绩验证。

在第二笔交易中,我们有一家全新的上市公司,大多数普通投资者可能都没听说过,至少目前还没有。它就是Freenome,一家专门利用人工智能进行癌症检测的公司,代码是FRNM。

in the second deal, we have a brand new public company , probably unheard of by most ordinary investors, at least not yet. It is Freenome, a company specializing in cancer detection using artificial intelligence, and its code is FRNM.

Google去年7月通过与一家特殊目的收购公司(SPAC)合并上市后,目前持有其约3000万美元的自有股份。查看股票走势图后,我们发现它经历了剧烈波动。在最近一次暴跌之后,其价格目前稳定在略低于首次公开募股(IPO)时的水平。

Google currently owns about $30 million of its own shares after going public last July through a merger with a special purpose acquisition company (SPAC). Upon reviewing the stock chart, we find that it has experienced sharp fluctuations.

After a recent crash, its price has now stabilized at a level slightly below its initial public offering (IPO) levels .